Back to top

Capricor surges on amended plans for lead drug; Cantor upgrades (update)

Capricor surges on amended plans for lead drug; Cantor upgrades (update)

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Capricor Therapeutics, Inc. (CAPR)